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Abstract
Background: Systems biology makes it possible to study larger and more intricate systems than before, so it is
now possible to look at the molecular basis of several diseases in parallel. Analyzing the interaction network of
proteins in the cell can be the key to understand how complex processes lead to diseases. Novel tools in network
analysis provide the possibility to quantify the key interacting proteins in large networks as well as proteins that
connect them. Here we suggest a new method to study the relationships between topology and functionality of
the protein-protein interaction network, by identifying key mediator proteins possibly maintaining indirect
relationships among proteins causing various diseases.
Results: Based on the i2d and OMIM databases, we have constructed (i) a network of proteins causing five
selected diseases (DP, disease proteins) plus their interacting partners (IP, non-disease proteins), the DPIP network
and (ii) a protein network showing only these IPs and their interactions, the IP network. The five investigated
diseases were (1) various cancers, (2) heart diseases, (3) obesity, (4) diabetes and (5) autism. We have quantified the
number and strength of IP-mediated indirect effects between the five groups of disease proteins and
hypothetically identified the most important mediator proteins linking heart disease to obesity or diabetes in the IP
network. The results present the relationship between mediator role and centrality, as well as between mediator
role and functional properties of these proteins.
Conclusions: We show that a protein which plays an important indirect mediator role between two diseases is
not necessarily a hub in the PPI network. This may suggest that, even if hub proteins and disease proteins are
trivially of great interest, mediators may also deserve more attention, especially if disease-disease associations are to
be understood. Identifying the hubs may not be sufficient to understand particular pathways. We have found that
the mediators between heart diseases and obesity, as well as heart diseases and diabetes are of relatively high
functional importance in the cell. The mediator proteins suggested here should be experimentally tested as
products of hypothetical disease-related proteins.
Background
The information in the human genome is sometimes so
crucial that simple changes can lead to severe inherita-
ble or chronic diseases. Genes related to causing dis-
eases are called disease genes [1] and their protein
products are disease proteins. Traditional biological and
medical methods to study those genes may require
expensive and laborious experiments. Thus there is a
great need to develop alternative (e.g., computational)
methods to understand them.
There is massive research on discovering disease genes
with various methods and data sources. Early works on
disease genes were based on either annotations (e.g. [2])
or sequence analysis (e.g. [3]). Generally, these methods
considered disease genes separately, as if they were inde-
pendent. However, we increasingly recognize that biolo-
gical processes are typically driven by the interplay of
complex interaction networks of various molecules
(mostly proteins). Not surprisingly, many human diseases
can be traced to aberrant protein-protein interactions,
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through the formation of a protein complex at an inap-
propriate time or location [4,5]. Therefore, it is encoura-
ging and promising to study disease genes in the context
of the complete protein interaction network.
Research on protein-protein interaction networks (PPI
network) and diseases has been much appealing in
recent years (see [6] for the k-nearest neighbor algo-
rithm, [7] for the phenomic ranking of protein com-
plexes and [8] for combining gene expression and PPI,
and [9] for the semi-supervised learning approach with
multiple data sources). Also, there are several work that
concentrated on studying disease genes for only one
specific disease (e. g. Alzheimer disease) using heuristic
score functions [10,11]. Key reviews on computational
methods for disease genes are provided by Kann [12]
and Ideker and Sharan [13].
In previous work, the direct associations of disease
proteins were brought into focus to predict disease pro-
teins. However, in complex diseases such as the ones
studied here, the rules that underlie the pathogenesis
are not only mutations in a single protein, but result
from complex interplay among them in the whole net-
work and genome-environment interactions. Conse-
quently, the association among proteins causing disease
is much more intricate. They may not directly affect
each other to cause disease, but indirectly, through a
mediator or a group of mediators.
As bioinformatics and systems biology offers large
databases and novel computational tools for better
understanding complex systems, we approach the dis-
ease-gene problem in a different way. Even if now it is
possible to quantify complexity and take a quantitative,
holistic approach, it is not yet easy to really understand
the indirect determination of biological processes. Here
graph theory and network analysis can be helpful. Net-
work analysis provides information about the local
(node-level) and global (whole graph-level) properties of
the system. For example, the degree distribution of a
complex network is a property that is global but based
on local, limited information on the positions of nodes
(reflecting only to neighbors, the rest of the network is
simply not considered while characterizing a given
n o d e ) .H o w e v e r ,t h e r ea r ean u m b e ro fm o r es o p h i s t i -
cated network analytical tools to explicitly measure
indirect relationships (for example, see [14,15]).
In this paper, we propose a new network analytical
method to quantify indirect effects among proteins in
their interaction network by using network indices
[16,17] and illustrate its use for studying PPI networks.
In particular, our aim is to quantify the indirect relation-
ships among proteins involved in five diseases, and to
characterize the proteins mediating these indirect
effects. The five diseases are cancer (C), diabetes (D),
obesity (O), heart diseases (H) and autism (A). The first
four ones belong to the major threats and mostly stu-
died disorders. Autism, on the contrary, is a relatively
minor disease. The autism genes were studied in this
work, since it seemed to be an interesting question how
a systems-based approach can or cannot reveal direct
and/or indirect effects between seemingly independent
diseases [18]. In addition, based on the number of scien-
tific publications, there is a fastest-growing interest in
autism and discovering possible cross-links can only be
a matter of time and effort. As it was earlier suggested
that functionally more important proteins are hubs and
disease proteins are peripheral ones in protein networks
[19], our interest is focused on whether the hubs are
mostly responsible for connecting these disease proteins
to each other. We concentrated on identifying the key
“mediator proteins” defined as non-disease proteins that
are interactive partners (IPs) of disease proteins in the
PPI network. We note here that a mediator protein may
well be considered a hypothetical disease protein which
is promisingly validated in wet-lab.
Results
Figure 1 shows the DPIP, while Figure 2 shows the IP
network analyzed. In the DPIP network, two heart dis-
ease proteins (P16671 and P17302) are directly linked to
a cancer protein (P12931) but no H proteins are linked
to A, O or D proteins. Among the IP proteins connect-
ing the otherwise unlinked sets of H and O proteins,
P12931(proto-oncogene tyrosine-protein kinase Src) was
the only non-IP protein mediating any effect. The most
influenced H protein was P18825 and the most influ-
enced O protein was P07550 (beta-2 adrenergic recep-
tor). The strongest indirect effect was mediated by
Q14232 (translation initiation factor eIF-2B subunit
alpha) (see Table 1 for mediator identity and Table 2
for relative strength of effects).
T h es a m ea n a l y s i sf o rt h em e d i a t o r sb e t w e e nt h eH
and D sets of disease proteins (see Additional files 1 and
2) shows that there are eight shared mediators appear-
ing in both links (H-O and H-D) but typically these
shared mediators are less important in both systems
(the exception is P63104 (14-3-3 protein zeta/delta)
being among the most important mediators in both
H-O and H-D pathways, marked by red in Additional
file 3). Here, P12931 was again the only non-IP media-
tor, the most influenced H protein was P18825 (alpha-
2C adrenergic receptor) again and the most influenced
D protein was P51681 (C-C chemokine receptor type 5).
The strongest indirect effect was mediated by P09471
(guanine nucleotide-binding protein G(o) subunit alpha).
We have determined the contribution of the other
four sets of disease proteins C, D, O, and A to influen-
cing the set of H proteins. By network analysis, it is
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can be expected from. For example, in case of the
P18825 H protein, although there are more than twice
as much O proteins than D proteins in this database,
the indirect effects reaching H proteins from D proteins
are stronger (39% of influence) than the ones originating
at O proteins (26% of influence). Based on the sheer
number of proteins, we would expect the contrary. Also,
even if proteins linked to autism (A) are apparently
independent of the rest of diseases, the strength of their
topological relationship is comparable to other diseases
(5% of influence). Cancer proteins, even if there are a
lot of them, contribute only to 30% of influence on
P18825.
Additional file 4 shows the hubs in the PPI and IP
networks (measured by nD and nB). Additional file 3
shows the most important mediators between H and O
as well as H and D disease proteins in the DPIP network
(measured by M
2). Some proteins are always of key
importance, like P63104, that is a hub and a key media-
tor. Others, like Q9Y4K3 (TNF receptor-associated fac-
tor 6) are hubs in the PPI network (high nD) and highly
central nodes in the IP network (high nB), but even
so, they are not mediating indirect effects between the
studied diseases.
Figure 3 shows that important mediators (high M
2 in
DPIP) are not necessarily hubs (high nD in PPI), but they
can be (see the outlier point representing P63104). Simi-
larly, Figure 4 shows that high-betweenness nodes in the
IP network are not necessarily the key mediators among
groups of disease proteins. These results are qualitatively
similar in the symmetrical cases (nD in IP and nB in IP).
Based on Figures 3 and 4, we can see that important
mediator proteins may have only a few neighbors.
We suggest that it can be of interest to study the rela-
tionship between network position and functionality of
proteins in the protein interaction network, even if our
work indeed did not intend to predict causing-disease
genes. Table 3 shows the statistics of enriched terms for
the information of interest. The relationship between the
M
2 index and the average P-value calculated for GO
terms of the mediators is demonstrated for both the H-O
(Figure 5) and the H-D (Figure 6) pathways. All of the P-
value of GO terms for the top mediators are below 0.05
(except for the H-D mediators P80098 (C-C motif che-
mokine 7) and P22681 (E3 ubiquitin-protein ligase
CBL)): it means that these mediators associate to rich
GO terms. The Pearson correlation (rH-O = 0.51) and the
Spearman rank order correlation (r =0 . 5 5 )s h o wt h a t
there is a relatively strong positive relationship between
M
2 and P-value of GO terms of the H-O mediators. For
the H-D mediators, the relationship is negative and not
very strong (with Pearson correlation rH-D = -0.14 and
the Spearman rank order correlation r = -0.32). The rela-
tionship between important mediator function (high M
2)
and functional importance (low average P-value) is stron-
ger in the case of diabetes (Figure 6).
Discussion
Apart of structural network analysis, understanding the
relationship between network position and biological
Figure 1 The DPIP network. The figure shows the DPIP network of
our study. It contains disease proteins and their interacting partners
(IPs). All hubs are cancer-related proteins. Figure drawn by [38].
Figure 2 The IP network. The figure shows the IP network analyzed.
It contains only IPs and the links among them. Figure drawn by [38].
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O\H P08254 P08588 P16671 P17302 P18825 P78504 Q14524 Q9UGJ0 Q9Y4J8
O00253
O75056 P06241 P41240
P01189
P07550 P49407 P62993 Q5JY77 P12931 P12931 P17252 P41240 Q14232
P13945 P12931 P12931
P25874
P29120
P32245
P37231 P28482
P41159 P54646
P41968
P48357
P52895
P55851 P63104
P55916 P63104
P81133
Q15466
Q16620 O14908 P06241
Q86YN6
Q9UBU3
Identity of mediator proteins among H proteins causing heart diseases (in columns) and O proteins causing obesity (in rows). Most of the mediators are IP
proteins, there is a single disease protein connecting the other two sets of disease proteins (P12931, belonging to C).
Table 2 Strengths of indirect effects between H and O proteins
O\H P08254 P08588 P16671 P17302 P18825 P78504 Q14524 Q9UGJ0 Q9Y4J8
O00253
O75056 0.0154 0.0155
P01189
P07550 0.0867 0.0005 0.0222 0.123
P13945 0.0013 0.0013
P25874
P29120
P32245
P37231 0.0071
P41159 0.0508
P41968
P48357
P52895
P55851 0.0583
P55916 0.0583
P81133
Q15466
Q16620 0.0575 0.012
Q86YN6
Q9UBU3
The relative strength of two-step-long indirect interactions (AH, O
2) mediated by mediators among heart disease and obesity. Column sums would give which H
protein is mostly influenced by O proteins (P18825), while row sums would give which O protein is mostly influenced by H proteins (P07550). The largest value
(0.123) indicates the strongest indirect effect between the two diseases (corresponding to Q14232, see Table 1).
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heart diseases and obesity, we have found several
enriched pathway terms related to diseases such as
‘insulin signaling pathway’, ‘aspirin blocks signaling
pathway involved in platelet activation’ and ‘natural
killer cell-mediated cytotoxicity’. ‘Kidney normal epithe-
lium 3
rd’ is an example for associated tissues for H-O
mediator proteins. The domains contained in these pro-
teins, such as S-Tck, SH2 and SH3, are important
domains in performing protein functions and are known
to be involved in different pathogenic mechanisms
[20,21].
The same procedure was used to explore functional
i n f o r m a t i o no nH - Dm e d i a t o r s .T h e r ea r et h r e e
enriched terms concerning pathways (’chemokine
families’, ‘long-term depression’ and ‘cytokine-cytokine
receptor’). Among these, ‘chemokine families’ are con-
sidered mostly pro-inflammatory: they can be induced
during immune response to promote immune cells to
the infection site, while others are considered homeo-
static and are involved in controlling cell migration dur-
ing normal tissue development. H-D mediators are
mostly located in tissues ‘adrenal tumor disease 3
rd’,
‘pancreatic tumor disease 3
rd’ and contain domains like
‘small inducible chemokine C/CC types’ and ‘small indu-
cible cytokine A2 type’. The above analyses reveal gener-
ally pathogenic roles of H-O and H-D mediators. The
following sections discuss some specific proteins of
interest in order to demonstrate the potential use of our
approach in systems biology and systems-based
medicine.
We have found that the strongest indirect effect was
mediated by P63104. This protein is the second ranked
mediator for both H-O and H-D by M
2 index. This
finding is in quite a concert with the spectrum of crucial
functions of P63104 in the cell. P63104 is indeed an
adapter protein implicated in the regulation of a large
spectrum of both general and specialized signaling path-
ways. As a result, it binds to a large number of partners,
usually by recognizing phosphoserine or phosphothreo-
nine motifs. Its binding generally results in the modula-
tion of the activity of the partners [22].
Another interesting mediator is C protein P12931,
which mediate both H-O and H-D pathways. Since
P12931 is involved in colorectal cancer [23], its central-
ity (based on any measure) is not surprising. P12931
(SRC_HUMAN) is the proto-oncogene tyrosine-protein
Figure 3 Degree and H/O mediator role. The importance of
mediator proteins between H and O disease proteins (measured by
M
2 in the DPIP network) is shown versus their nD in the PPI
network. Important mediators among disease proteins are not
necessarily hub proteins in the cell.
Figure 4 Betweenness and H/O mediator role.T h ei m p o r t a n c e
of mediator proteins between H and O disease proteins (measured
by M
2 in the DPIP network) is shown versus their nB in the IP
network. Important mediators are not necessarily high-betweenness
nodes in IP.
Table 3 Functional statistics of mediator proteins
GO term Pathway Tissue Domain
H-O mediator 67 49 73 90
H-D mediator 70 2 24 16
Statistics of data/terms regarding the GO terms, pathway, tissue, and domain
information on the most important mediator proteins in the heart-obesity
(H-O) and heart-diabetes (H-D) pathways.
Figure 5 Function and H/O mediator role. The figure shows the
average P-value (avP) of GO terms against the importance of the 11
most important mediator proteins (measured by M
2) in H-O
pathways. The P-value quantifies the significance of GO term
enrichment with a modified Fisher’s exact test.
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protein kinase family and SRC subfamily. P12931 con-
tains one protein kinase domain, one SH2 domain and
one SH3 domain. This tyrosine-protein kinase plays its
role in various signal transduction pathways in the cell,
such as signaling by NGF, homeostasis, signaling in the
immune system, signaling by EGFR as well as in the
“gap junction trafficking and regulation” process.
P12931 mediates two types of disease proteins
(P08588 (H), P16671 (H), P07550 (O) and P13945 (O)).
Looking at the functionality of P16671 (CD36_HU-
MAN), P08588 (ADRB1_HUMAN), P07550 (ADRB2_-
HUMAN; the most influenced O protein) and P13945
(ADRB3_HUMAN), we see that these proteins all have
receptor functions. Therefore, indirect effects of disor-
ders may be performed by P12931 in cell signaling.
In addition, we have studied the most influenced pro-
teins of heart diseases, obesity, and diabetes. The most
influenced heart disease protein, P18825 (ADA2C_HU-
MAN) was found to synergistically influence the ejection
fraction response to beta-blocker therapy of heart failure
patients [24]. P18825 is an alpha-2 adrenergic receptor,
mediating the catecholamine-induced inhibition of ade-
nylate cyclase through the action of G proteins, belong-
ing to the G-protein coupled receptor 1 family. P18825
relates to the activation of MAPK activity and cell-cell
signaling. Alpha-2-adrenergic receptors have a critical
role in regulating neurotransmitter release from sympa-
thetic nerves and from adrenergic neurons in the central
nervous system.
The most influenced diabetes protein was P51681
(CCR5_HUMAN), C-C chemokine receptor type 5, a
receptor for a number of inflammatory CC-chemokines
including MIP-1-alpha, MIP-1-beta and RANTES. Its
signal transduction is based on increasing the intracellu-
lar calcium ion level. The genetic variation in CCR5 is
associated with susceptibility to insulin-dependent dia-
betes mellitus type 22 (IDDM22, [25]). IDDM is caused
by the body’s own immune system which destroys the
insulin-producing beta cells in the pancreas. Classical
features are polydipsia, polyphagia and polyuria, due to
hyperglycemia-induced osmotic diuresis. Like P12931,
P51681 is involved in the interaction between the host
cell’s macromolecular machinery and viral proteins.
The most influenced O protein is P07550 (ADRB2_HU-
MAN), Beta-2 adrenergic receptor. Beta-adrenergic recep-
tors mediate the catecholamine-induced activation of
adenylate cyclase through the action of G proteins.
P07550 belongs to the group of disulfide bond, glycopro-
tein, lipoprotein, palmitate and phosphoprotein. The find-
ings of Large et al. [26] suggested that genetic variation in
the ADRB2 gene might be of major importance for obe-
sity, energy expenditure, and lipolytic ADRB2 function in
adipose tissue, at least in women [26]. Tsai et al. [27]
reported a significant association between a -47C-T poly-
morphism (arg-19cys; R-19C) in the beta-upstream pep-
tide of the ADRB2 gene and bronchodilator drug response
among 264 African American children with asthma [27].
Conclusions
We illustrate that understanding the role and impor-
tance of individual genes highly depends on how to
define the network of study: proteins appearing as hubs
in the PPI network may be of lower topological impor-
tance in mediating indirect effects among groups of dis-
ease proteins (in the DPIP network, see [28]). By
quantitatively identifying, the most important mediator
genes are seemingly unimportant but play key roles in
maintaining communication between disease genes and
these mediators are not hubs in PPI. We suggest that
the central proteins in the IP network can be even more
important in systems-based medicine and drug design
than either the hubs or the disease proteins themselves.
The proteins mediating indirect interactions among the
studied disease proteins were found to be generally of
high functional importance in the cell (for example
P63104). Even if obesity and diabetes-related proteins
are not directly linked to heart-disease proteins, rich
indirect linkages can be realized through, for example,
the insulin signaling pathway or the P12931 proto-onco-
gene tyrosine-protein kinase Src. We propose that our
results should call for experimental studies on the rele-
vance of this approach.
Methods
Data
We investigated two main databases: the i2d database as
a comprehensive human protein interaction database
(formerly known as OPHID [29]), and the OMIM data-
base as a well-known disease gene database [30]. The
Figure 6 Function and H/D mediator role. The figure also shows
the average P-value (avP) of GO terms against the importance of
the 11 most important mediator proteins (measured by M
2) in H-D
pathways. The P-value quantifies the significance of GO term
enrichment with a modified Fisher’s exact test.
Nguyen and Jordán BMC Systems Biology 2010, 4:103
http://www.biomedcentral.com/1752-0509/4/103
Page 6 of 11i2d database is an on-line database of known and pre-
dicted mammalian and eukaryotic protein-protein inter-
actions. It consists of almost all human protein
interaction data sets (including HRPD, BIND, etc), and
this is the reason why we chose the i2d database for our
analysis. To obtain a more reliable set of protein inter-
actions, we excluded all the interactions obtained by
homology methods. Identifier (ID) of protein in the i2d
database is the protein ID defined in the UniProt data-
base [31]. The OMIM database is a catalog of human
genes and genetic disorders. In OMIM, the list of her-
editary disease genes is described in the OMIM morbid
map. To extract the list of genes related to five, we
searched for all genes having the keywords “cancer”,
“heart disease”, “diabetes”, “autism” and “obesity”.O u r
study considered the database version released in Janu-
ary 2009. By using a mapping scheme, product proteins,
so-called disease proteins corresponding to the disease
genes in the OMIM database, are identified by UniProt
protein IDs. We then did a preprocess procedure to fil-
ter noise data (for both i2d-based PPI data and OMIM-
based disease protein data). We note that improved
databases will probably influence the actual results but
considering also another disease in the same database
does not. Characterizing the linkage between heart dis-
ease and obesity proteins, for example, is not influenced
by analyzing some additional kind of disease proteins.
Based on these data sets, we have constructed (1) a
human protein-protein interaction network (PPI), (2) a
network of disease proteins (DP) causing five selected
diseases plus their interacting partners (IP; called the
DPIP network) and (3) a protein network of IPs with
interactions among them (IP network, see Figure 1).
The DPIP and the IP networks are subgraphs of the PPI
network. The IP network is not a subgraph of the DPIP
network, since it contains IP-IP interactions not
included in the DPIP network - the network of only
DP-DP and DP-IP interactions.
After preprocessing, the PPI network contained 12513
nodes and 60675 links. In the DPIP network, there were
2777 nodes (9 H, 9 A, 20 D, 44 O, 90 C and 2349 IP
proteins). Most pairs of diseases had also direct links
between their protein sets (like some A proteins with C
proteins and some A proteins with D proteins), but four
p a i r s( Ha n dO ,Ha n dD ,Ha n dAa n dOa n dA )w e r e
only indirectly linked (mostly through IPs, but rarely
also through other disease proteins, predominantly C).
Links in each network were considered undirected and
un-weighted. We considered only two-step-long indirect
interactions between proteins (note that longer pathways
link each pair of nodes in a network, but longer indirect
effects may be of less practical relevance).
Network analysis
One of the key interests of systems biology is to under-
stand the components of biological systems in a wider,
non-local context. In a network model, this means the
analysis of network nodes also from the viewpoint of
indirect linkages and determination. Various centrality
indices provide a rich toolkit for quantifying the non-
local neighborhood of graph nodes in directed and
undirected (symmetrical), binary and weighted as well as
signed and unsigned networks. In particular, we use
here local (node degree), non-local (betweenness cen-
trality) and non-local, short-range (topological impor-
tance in two steps) network measures.
Here we were interested in finding the proteins of
central positions in the network, as they can be highly
important also from a functional point of view (see
[32]). A graph model of a biological system is composed
of N nodes and M links connecting them, where nodes
and links can represent proteins and protein interac-
tions, for example. The number of neighbors for node i
(Di, its degree) provides a quick look at how richly a
protein is linked to others: high-degree nodes are called
hubs and can be considered of high structural impor-
tance. Normalized degree (nDi) is suitable for analyses
where there are networks of different size to analyze:
nD
Di
N
i =
−
⋅
1
100 (1)
where N is the number of nodes in the network and
auto-loops are not considered (Additional file 4 shows
the nD values for all nodes in each of the three studied
networks, as well as their ranks).
Degree is a local network metric, but other centrality
measures are capable of providing additional informa-
tion, for example, also on the number of neighbors of
neighbors (i.e. how richly the neighbors are linked).
There is a rising interest in indirect network measures
in molecular and cell biology, e.g. [33,34], following
other fields of biology. For example, the betweenness
centrality of node i (Bi, [35]) measures how frequently
node i is incident to all shortest paths between the
other pairs of nodes j and k in the network:
B
g jk i jk
g jk
i = > ∑ ()
(2)
where i ≠ j ≠ k, gjk is the number of equally shortest
paths between nodes j and k,a n dgjk(i) is the number of
these shortest paths which node i is incident to. For
studying different networks, the normalized value (nBi)
is suitable:
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Bi
NN
i =
⋅
−⋅ −
2
12 () ()
(3)
w h e r eNi st h en u m b e ro fn o d e si nt h en e t w o r ka n d
auto-loops are not considered (Additional file 4 shows
the nB values for all nodes in each of the three studied
networks, as well as their ranks).
Another index measuring indirect neighborhood of
graph nodes is the topological importance (TIi
n)i n d e x
[16,17]. It is suitable if the topological relationship
between particular nodes i and j are to be quantified,
even if i and j a r en o tl i n k e d :t h eT I i
n index quantifies
the expected strength of indirect effects between them,
mediated by one or several mediator node(s). If i and j
are linked through k, it can also be quantified how large
is the contribution of k to connecting i and j (relative to
other pathways of shorter, equal or longer length).
We assume a network with undirected links where
effects can spread in any direction with the same prob-
ability. Here, we define aij
n as the effect of node j on
node i when i can be reached from j in exactly n steps.
The simplest mode of calculating aij
n is when n = 1 (i.e.
the effect of node j on node i in 1 step):
a
Di
ij
1 1
= (4)
where Di is the degree of node i (i.e. the number of its
neighbors). We assume that indirect effects are multipli-
cative and additive: if we wish to determine the effect of
Figure 7 A toy network illustrating how to measure indirect effects. In this toy PPI network, there are two disease proteins, a red (D degree
= 3) and a black (D = 7) one. Their interacting partners (IPs) are colorful: the green (D = 2) and the yellow (D = 5) nodes mediate two-step-long
indirect effects between disease proteins, the blue ones do not. White nodes are not IPs. The PPI network contains all nodes, the DPIP network
contains all colorful nodes but no links among IPs, while the IP network contains only IPs and the links among them. The strength of the effect
from the red node to the green one is 1/2, and from the green to the black node it equals 1/7, thus, the red-green-black pathway is of strength
1/14. Similarly, the red-yellow-black pathway is of strength 1/5*1/7 = 1/35. Additively, the two-step-long indirect effects from red to black equal
1/14+1/35 = 49/490 = 1/10. From black to red, the strength of two-step-long indirect influence is (1/5*1/3)+(1/2*1/3) = 7/30. The summed
mutual dependence equals 7/30+1/10 = 10/30 = 1/3. The relative contribution of the two mediator proteins are 1/15+1/35 = 50/525 = 0.095
(yellow) and 1/14+1/6 = 20/84 = 5/21 = 0.238 (green). Figure drawn by [38].
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Page 8 of 11node j on node i in two steps, and there are two such
two-step pathways (one through k and the other
through f), then the effects of j on i through k is defined
as the product of two direct effects:
aa a ij k kj ik ()
21 1 =⋅ (5)
(therefore the term multiplicative), and similarly, the
effect of j on i through f equals
aa a ij f fj if ()
21 1 =⋅ (6)
Further, to determine the overall two-step effect of j
on i (aij
2), we simply sum up the effects mediated by
different two-step pathways (through k and through f):
aa aa a ij kj ik fj if
21 11 1 =⋅+⋅ (7)
(therefore the term additive). Now we are interested
only in two-step long pathways but this method can
also be used for longer indirect pathways (also in
weighted graphs, see [17]). A software called SilInd 1.2
(code available from Dr. Liu: wliu56@gate.sinica.edu.tw)
can calculate these indices, so effects can be measured
for single aij interactions and aij(k) pathways, as well as
the total topological importance of graph node j can be
measured as the sum of its effects on other nodes:
TI a i j j
n
ij
n
i
N
=≠ {}
= ∑ 1
(8)
where N is the number of nodes in the network and
effects are mediated through n-step pathways.
Based on this, it can be determined how the proteins
of a certain disease (disease 1, D1) are topologically
related to proteins of another disease (disease 2, D2):
Aa i D j D DD
n
ij
n
ij
N
12 12 1 , ,
; =∈ ∈ {}
= ∑ (9)
A
n
D1;D2 is zero if there are no proteins involved in
causing “disease 1” that is linked (within n steps) to any
of the proteins involved in “disease 2”.H i g h e rv a l u e s
mean several n-step-long pathways between the two sets
of proteins being involved in the two diseases. The role
o fas i n g l ep r o t e i nk in mediating a two-step long path-
way between i and j can also be quantified:
M
Dk Di Dj
k
2 11 1
=⋅ +
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
(10)
that quantifies mediated effects in both directions (see
also Figure 7 for explanation).
Apart of the structural analysis of proteins in the PPI,
DPIP and IP networks, we were also interested in the
biological functions of most important mediator pro-
teins (measured by M
2 in the DPIP network, see Addi-
tional file 3). We analysed the 11 H-O mediators and,
accordingly, the 11 most important ones for H-D path-
ways (out of 24). We studied their pathways, tissues and
GO terms extracted from the DAVID database system
([36,37], http://david.abcc.ncifcrf.gov/). The DAVID
database is a high-throughput and integrated data-
mining environment to systematically study gene lists
derived from high-throughput genomic experiments.
Additional files 5 and 6 show information on main GO
categories (MF: molecular function, BP: biological pro-
cess and CC: cellular component), GO terms (e.g. cell
death), count (how many proteins out of 11 are charac-
terized by the given GO term), the P-value of the GO
term in the database and, finally, the list of the proteins
counted. Additional files 5 and 6 provide information
on mediators in H-O and H-D pathways, respectively.
Each mediator protein is characterized by the average P-
value of all GO terms characterizing it (see Table 4).
The relationships between M
2 index and the average P-
value calculated for GO terms of the mediators in H-O
and H-D are then measured by Pearson and Spearman
rank order correlation by using Free Statistics Software,
Office for Research Development and Education, version
1.1.23-r6 http://www.wessa.net/.
Additional material
Additional file 1: Identity of mediator proteins among H proteins
causing heart diseases (in columns) and D proteins causing
diabetes (in rows). Most of the mediators are IP proteins (in black),
there is a single disease protein connecting the other two sets of disease
proteins (P12931, belonging to C, in red).
Table 4 P-values of most important H-O and H-D
mediators
H-O
protein
avP H-D
protein
avP
Q5JY77 0.0454 P13500 0.0633
P63104 0.0453 P05129 0.0590
O14908 0.0405 P07948 0.0511
Q14232 0.0356 P22681 0.0370
P17252 0.0345 P09471 0.0342
P28482 0.0328 P63104 0.0282
P49407 0.0305 P80098 0.0271
P06241 0.0269 P80075 0.0234
P62993 0.0244 Q99962 0.0198
P41240 0.0220 Q99616 0.0153
P54646 0.0191 P48745 0.0120
The average P-values (avP) of the most important 11 mediator proteins in the
heart-obesity (H-O) and heart-diabetes (H-D) pathways. Note that smaller
P-values mean functionally more important proteins.
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Page 9 of 11Additional file 2: The relative strength of two-step-long indirect
interactions (AH,D
2) mediated by mediators among H and D. Column
sums would give which H protein is mostly influenced by D proteins
(P18825), while row sums would give which D protein is mostly
influenced by H proteins (P51681). The largest value (0.17983) indicates
the strongest indirect effect between the two diseases (corresponding to
P09471, see Additional file 1).
Additional file 3: The most important mediator proteins are shown
among H and O as well as H and D sets of disease proteins, ranked
according to their mediation strength M
2 (calculated for the DPIP
network).
Additional file 4: the values and ranks of nD and nB values for the
nodes of the PPI, DPIP and IP networks. Also, the nD vs nB
relationships and the value rank column diagrams are given for
each network.
Additional file 5: the count, P-value and identity of H-O mediator
proteins chracterized by particular GO categories and terms.
Additional file 6: the count, P-value and identity of H-D mediator
proteins chracterized by particular GO categories and terms.
Abbreviations
DPIP NETWORK: the network of Disease Proteins plus their Interacting
Partners; I2D: Interologous Interaction Database; IP NETWORK: the network of
Interacting Partners of disease proteins; OMIM: Online Mendelian Inheritance
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